(IMAGE)
Caption
The diagram shows how increased sST2 levels in AD impair microglial clearance of amyloid pathology: increased levels of sST2 protein (1) in the blood enter the brain; this decoy receptor blocks the normal signaling stimulated by IL-33 in microglia (2). The inhibition of IL-33 signaling leads to reduced clearance of Aβ by microglia (3), resulting in an increase in Aβ plaque load (4).
Credit
HKUST
Usage Restrictions
N.A.
License
Original content